A detailed history of Jaffetilchin Investment Partners, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Jaffetilchin Investment Partners, LLC holds 6 shares of UTHR stock, worth $2,165. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Holding current value
$2,165
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$311.04 - $363.55 $1,866 - $2,181
6 New
6 $2,000
Q2 2020

Jul 31, 2020

BUY
$92.74 - $125.82 $1.06 Million - $1.44 Million
11,476 New
11,476 $0

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Jaffetilchin Investment Partners, LLC Portfolio

Follow Jaffetilchin Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.